August 8, 2008 04:27 PM
August 8, 2008 11:14 AM
August 8, 2008 07:53 AM
August 7, 2008 01:58 PM
August 7, 2008 01:18 PM
August 7, 2008 06:45 AM
August 6, 2008 11:27 PM
To add an specific blogger's feed, simply go to their blog and click on their individual RSS link.
Before you read this post, please know that I do not own this stock, although I do recommend it in my service. I'm exposing this because it's a hatchet job done on a product category that can save tens-of-thousands of lives -- and because a company's stock took a hit for no reason.
That company, Cepheid (CPHD), took a major hit yesterday after the close, due to an article in the Journal of the American Medical Association -- an article that should never have been published.
If it was vetted, then the people who agreed to its publication should check into a hospital that doesn't do any MRSA testing the next time they aren't well.
The article claimed that MRSA testing did not help reduce MRSA infections -- which of course is not only illogical but utter nonsense if you live in the real world.
Find out all the reasons the drop in Cepheid was unjustified.